Catalyst Wire Dossier Catalyst Wire Dossier

ticagrelor (Brilinta/Brilique)

ticagrelor · AstraZeneca
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ticagrelor (Brilinta/Brilique), covering 2018-06-14 to 2018-06-14. Get the full timeline:

Most recent: Clinical Trial Update: Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes

See pricing